These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 6171098
41. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins. Wallach D. J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250 [Abstract] [Full Text] [Related]
42. [Biological characteristics of new interferon inducers created on a gossypol base]. Saĭitkulov AM, Tazulakhova EB, Sarymsakov AA, Ershov FI. Vopr Virusol; 1984 Oct; 29(6):749-51. PubMed ID: 6084903 [No Abstract] [Full Text] [Related]
43. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. Haasbach E, Droebner K, Vogel AB, Planz O. J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570 [Abstract] [Full Text] [Related]
44. Protein kinase C and the antiviral effect of human interferon. Cernescu C, Constantinescu SN, Baltă F, Popescu LM, Cajal N. Virologie; 1989 Jun; 40(3):163-70. PubMed ID: 2480687 [Abstract] [Full Text] [Related]
45. Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. Alber D, Staeheli P. J Interferon Cytokine Res; 1996 May; 16(5):375-80. PubMed ID: 8727077 [Abstract] [Full Text] [Related]
46. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. Weber JM, Stewart RB. J Gen Virol; 1975 Sep; 28(3):363-72. PubMed ID: 170377 [Abstract] [Full Text] [Related]
47. In vitro interferon production by bovine tissues: induction with infectious bovine rhinotracheitis virus. Fulton RW, Rosenquist BD. Am J Vet Res; 1976 Dec; 37(12):1497-502. PubMed ID: 187093 [Abstract] [Full Text] [Related]
48. Association of mouse interferon with liposomes. La Bonnardière C. FEBS Lett; 1977 May 15; 77(2):191-6. PubMed ID: 193734 [No Abstract] [Full Text] [Related]
54. Rat leukocyte interferons: production of an acid-labile interferon after induction with Newcastle disease virus. Wiedbrauk DL, Burleson GR. J Leukoc Biol; 1987 Jul 15; 42(1):21-9. PubMed ID: 2439625 [Abstract] [Full Text] [Related]
55. Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells. Havell EA. Arch Virol; 1980 Jul 15; 65(3-4):229-36. PubMed ID: 6158304 [Abstract] [Full Text] [Related]
56. [A PERSPECTIVE CULTURAL MODEL FOR CONTROL OF BIOLOGICAL ACTIVITY OF HUMAN INTERFERONS]. Nagieva FG, Barkova EP, Fedotov AY, Gaiderova LA, Lisakov AN, Nochevny VT. Zh Mikrobiol Epidemiol Immunobiol; 2015 Jul 15; (5):39-44. PubMed ID: 26829852 [Abstract] [Full Text] [Related]
59. Interferon production by mouse leukocytes in vitro and in vivo. GLASGOW LA, HABEL K. J Exp Med; 1963 Jan 01; 117(1):149-60. PubMed ID: 13948365 [Abstract] [Full Text] [Related]
60. A convenient and rapid cytopathic effect inhibition assay for interferon. Familletti PC, Rubinstein S, Pestka S. Methods Enzymol; 1981 Jan 01; 78(Pt A):387-94. PubMed ID: 6173617 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]